BioCentury Publications Revenue and Competitors
Estimated Revenue & Valuation
- BioCentury Publications's estimated annual revenue is currently $14.3M per year.
- BioCentury Publications's estimated revenue per employee is $155,000
Employee Data
- BioCentury Publications has 92 Employees.
- BioCentury Publications grew their employee count by 0% last year.
BioCentury Publications's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President & CEO | Reveal Email/Phone |
2 | VP & CFO | Reveal Email/Phone |
3 | VP and Editor in Chief | Reveal Email/Phone |
4 | Head Customer Experience | Reveal Email/Phone |
5 | Creative Director | Reveal Email/Phone |
6 | Director Data & Analytics | Reveal Email/Phone |
7 | Director Biopharma Intelligence | Reveal Email/Phone |
8 | Senior Director | Reveal Email/Phone |
9 | Executive Director, Biopharma Intelligence | Reveal Email/Phone |
10 | Chief Technology Officer | Reveal Email/Phone |
BioCentury Publications Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $56.4M | 364 | 76% | N/A | N/A |
What Is BioCentury Publications?
BioCentury Publications, Inc. is an independently owned and operated company based in Redwood City, Calif., that provides essential biopharma industry intelligence from five offices in the U.S. and Europe. Over the past 15 years, a global audience of biotech and pharmaceutical executives and investors has benefited from BioCentury's deep knowledge, data-driven analysis and independent perspective. BioCentury's trustworthy content is available through the company's publications, including BioCentury, the Bernstein Report on BioBusiness and the new SciBX: Science-Business eXchange, as well as its BCIQ: BioCentury Online Intelligence database, which helps filter, analyze and identify candidates from more than 4,000 companies, 5,000 compounds and $200 billion in financing transactions, and its collaborative industry conferences in the U.S., Europe and Asia. For more information, visit www.biocentury.com.
keywords:N/A
N/A
Total Funding
92
Number of Employees
$14.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioCentury Publications News
The response to the Covid-19 pandemic by drug and vaccine developers has been swift. BioCentury lists more than 400 unique compounds — small molecules, antibodies, and vaccines — that are currently in clinical development for Covid-19. Yet the success of this work is at risk due to an invisible ...
LIFE SCIENCES Replimune raised $30 million in a Series A round led by Atlas Venture to develop next-generation oncolytic viruses for cancer. — BioCentury Intarcia Therapeutics acquired former GlaxoSmithKline’s Phoundry Pharma. – MassDevice Arrowhead Research got solid Phase IIa clinical trial ...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.2M | 92 | 6% | N/A |
#2 | $13.4M | 96 | -39% | $53.2M |
#3 | $23.8M | 97 | 9% | N/A |
#4 | $13.6M | 97 | 4% | $91.8M |
#5 | $11.8M | 98 | 34% | N/A |